Evid Invest
Who owns CGWhat CG owns

What The Carlyle Group Inc. owns

The company's own 13F portfolio · as of 2026-03-31 · long US-listed stakes only — private holdings, bonds and cash are not disclosable on a 13F

$10.62B

disclosed stock portfolio

20

positions

78.4%

in MDLN

Positions, as of 2026-03-31

ordered by filed value · % of book = share of the disclosed stock portfolio · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1MDLNMedline Inc187.1M$8.33B78.4%
2SAROStandardaero Inc84.6M$2.18B20.6%
3PHATPhathom Pharmaceuticals Inc3.5M$38.8M0.4%
4PONYPony Ai Inc2.4M$22.3M0.2%
5INVHInvitation Homes Inc664,100$16.5M0.2%
6CUBECubeSmart220,500$8.1M0.1%
7Q32 Bio Inc1.1M$7.1M0.1%
8Getty Images Holdings Inc6.2M$4.9M0%
9Spruce Biosciences Inc38,620$2.5M0%
10FWRDForward Air Corp107,214$1.8M0%
11Adicet Bio Inc184,295$1.3M0%
12Krispy Kreme Inc340,748$1.2M0%
13Onkure Therapeutics Inc269,895$1.1M0%
14Jasper Therapeutics Inc1.1M$934,1950%
15SunPower Inc433,158$550,1110%
16HTFLHeartflow Inc20,438$497,2560%
17SYRESpyre Therapeutics Inc9,620$485,2330%
18NABLN-able Inc93,732$437,7280%
19Exicure Inc56,328$239,6470%
20HOODRobinhood Mkts Inc3,376$233,9570%

Source: SEC Form 13F-HR filed by Carlyle Group Inc. (CIK 1527166), reporting period 2026-03-31. Values are quarter-end filed marks. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.